Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.

The company recently released phase 3 data showing that a twice-yearly treatment with lenacapavir was 100% effective in HIV ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

Marine, not her real name, was considering surgery to deal with intense pain. Three doctors refused to see her before a ...

In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...

"Madagascar’s HIV epidemic is being fueled by gaps in prevention and glaring inequalities, which urgently need to be ...

Health NGO, Right to Care, highlights the urgent need for circumcision among boys aged 15 and older in KwaZulu-Natal to ...

Such registration is required before the jab can be marketed for prevention. Lenacapavir injections are already registered in some countries as a last resort treatment for HIV, but not yet in South ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for people like Anna Engomba, the arrival of new, life-saving medication cannot ...